, Tracking Stock Market Picks
Enter Symbol:
Tenet Healthcare Corporation (THC) [hlAlert]

up 117.22 %

Tenet Healthcare Corporation (THC) upgraded to Overweight by Lehman Brothers

Posted on: Thursday,  Jun 12, 2008  8:25 AM ET by Lehman Brothers

Lehman Brothers rated Overweight Tenet Healthcare Corporation (NYSE: THC) on 06/12/2008, when the stock price was $22.88. Since
then, Tenet Healthcare Corporation has gained 117.22% as of 01/21/2016's recent price of $49.70.
If you would have followed this Lehman Brothers's recommendation on THC, you would have gained 117.22% of your investment in 2779 days.

Tenet Healthcare Corporation (Tenet) is an investor-owned health care services company, whose subsidiaries and affiliates principally operate general hospitals and related health care facilities. The Company?s operations are conducted through its subsidiaries. As of December 31, 2008, Tenet?s subsidiaries operated 53 general hospitals, a cancer hospital and a critical access hospital, with a combined total of 14,352 licensed beds, serving urban and rural communities in 12 states. Of those general hospitals, 45 were owned by the Company?s subsidiaries and eight were owned by third parties and leased by its subsidiaries (including one hospital Tenet owned located on land leased from a third party). In August 2008, the Company announced that it has completed the previously disclosed sale of its entire interest in Broadlane, Inc. to TowerBrook Capital Partners L.P. In November 2008, Tenet announced the formation of a wholly owned operating subsidiary, Conifer Health Solutions, Inc.

Lehman Brothers Holdings Inc. has filed for bankruptcy protection in the U.S.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/12/2008 8:25 AM Buy
as of 12/24/2008
1 Week up  35.25 %
1 Month up  77.31 %
3 Months up  81.89 %
1 YTD down  -48.02 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2008 8:25 AM Hold
8/8/2007 9:25 AM Sell
16.72 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy